본문 바로가기

Data Plus(+)

All 807,818 Page 9,995/80,782

검색

Contents

No Journal_name Subject Date DOI Author
707878 FRONTIERS IN ONCOLOGY Nonsmoking and Nondrinking Oral Squamous Cell Carcinoma Patients: A Different Entity 2021-06-28 10.3389/fonc.2021.558320 Yang Zhan, Du Wei, Zhang Xu, Chen Defeng, Fang Qigen, He Yuezhong, Yang Yang, Li Ding, Fan Jie
707877 FRONTIERS IN ONCOLOGY Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial 2021-06-28 10.3389/fonc.2021.686776 Schettini Francesco, Corona Silvia Paola, Giudici Fabiola, Strina Carla, Sirico Marianna, Bernocchi Ottavia, Milani Manuela, Ziglioli Nicoletta, Aguggini Sergio, Azzini Carlo, Barbieri Giuseppina, Cervoni Valeria, Cappelletti Maria Rosa, Molteni Alfredo, Lazzari Maria Chiara, Ferrero Giuseppina, Ungari Marco, Marasco Elena, Bruson Alice, Xumerle Luciano, Zago Elisa, Cerra Davide, Loddo Marco, Williams Gareth H., Paris Ida, Scambia Giovanni, Generali Daniele
707876 FRONTIERS IN ONCOLOGY Application of and Clinical Research on Enhanced Recovery After Surgery in Perioperative Care of Patients With Supratentorial Tumors 2021-06-28 10.3389/fonc.2021.697699 Wu Jingmi, Zhang Weina, Chen Jie, Fei Hui, Zhu Hong, Xie Haofen
707875 FRONTIERS IN ONCOLOGY A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy 2021-06-28 10.3389/fonc.2021.653002 Kim Sung Han, Park Boram, Hwang Eu Chang, Hong Sung-Hoo, Jeong Chang Wook, Kwak Cheol, Byun Seok Soo, Chung Jinsoo
707874 FRONTIERS IN ONCOLOGY Case Report: Low-Dose Apatinib in the Treatment of Intrahepatic Biliary Cystadenoma With Recurrence and Malignant Transformation 2021-06-28 10.3389/fonc.2021.676092 Yang Yongguang, Mai Weiheng, Chen Weifeng, Yang Chao, Li Mingyi, Liu Lijuan
707873 FRONTIERS IN ONCOLOGY Case Report: Treatment of Alectinib in NSCLC With Brain Metastasis Patient Refractory to Radiotherapy After Resistance to Crizotinib 2021-06-28 10.3389/fonc.2021.709188 Zhang Chunzhi
707872 FRONTIERS IN ONCOLOGY Tumor Microenvironment Alters Chemoresistance of Hepatocellular Carcinoma Through CYP3A4 Metabolic Activity 2021-06-28 10.3389/fonc.2021.662135 Özkan Alican, Stolley Danielle L., Cressman Erik N. K., McMillin Matthew, DeMorrow Sharon, Yankeelov Thomas E., Rylander Marissa Nichole
707871 FRONTIERS IN ONCOLOGY Efficacy of Anlotinib for the Treatment of Angiosarcoma of the Face and Neck: A Case Report 2021-06-28 10.3389/fonc.2021.596732 Ren Biyong, Wang Wei, Tan Jing, Yuan Bo, Chen Guilan, Mo Xiaofei, Fan Jieqiong, Yang Bo, Huang Xiaoping
707870 FRONTIERS IN ONCOLOGY Corrigendum: Value of Pyruvate Carboxylase in Thyroid Fine-Needle Aspiration Wash-Out Fluid for Predicting Papillary Thyroid Cancer Lymph Node Metastasis 2021-06-28 10.3389/fonc.2021.724796 Liu Chang, Zhang Lu, Liu Yang, Zhao Qingqing, Pan Yu, Zhang Yifan
707869 FRONTIERS IN ONCOLOGY The Proton-Boron Reaction Increases the Radiobiological Effectiveness of Clinical Low- and High-Energy Proton Beams: Novel Experimental Evidence and Perspectives 2021-06-28 10.3389/fonc.2021.682647 Bláha Pavel, Feoli Chiara, Agosteo Stefano, Calvaruso Marco, Cammarata Francesco Paolo, Catalano Roberto, Ciocca Mario, Cirrone Giuseppe Antonio Pablo, Conte Valeria, Cuttone Giacomo, Facoetti Angelica, Forte Giusi Irma, Giuffrida Lorenzo, Magro Giuseppe, Margarone Daniele, Minafra Luigi, Petringa Giada, Pucci Gaia, Ricciardi Valerio, Rosa Enrico, Russo Giorgio, Manti Lorenzo